EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors

On March 28, 2019, the Committee for Medicinal Products for Human Use adopted a positive opinion recommending the marketing authorization for the medicinal product plerixafor. The marketing authorization holder for this medicinal product is Genzyme Europe B.Th. The adoption was for an extension of t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Karres, Dominik, Ali, Sahra, van Hennik, Paula B., Straus, Sabine, Josephson, Filip, Thole, Geanne, Glerum, Pieter J., Herberts, Carla, Babae, Negar, Herold, Ralf, Papadouli, Irene, Pignatti, Francesco
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Regulatory Issues: EMA
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288649/
https://ncbi.nlm.nih.gov/pubmed/32154610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0898
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki